Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 4Withdrawn 2Terminated 2

Sponsor Class

OTHER 4INDUSTRY 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Lymphoid 1CNS 1Breast 1

Conditions

Carcinoma, Hepatocellular 2Lymphoma 1Liver Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × OTHER × gadobenic acid × Clear all
NCT03703492 2025-02-12

Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS

University of Wisconsin, Madison

Phase 2 Completed
12 enrolled 9 charts
Breast

Breast Neoplasms

NCT04132843 2022-11-21

Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions

M.D. Anderson Cancer Center

Phase NA Completed
6 enrolled
CNSLymphoid

Brain Neoplasms, Lymphoma

NCT00539253 2017-09-26

TACE

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Completed
45 enrolled 5 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02226666 2017-01-13

Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration

University of Michigan

Completed
107 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡